Although SARS-CoV-2-specific CD8+ T cells have been characterized in detail in immunocompetent individuals [12,13,14,15,16,17,18,27,28,29,30], SARS-CoV-2-specific CD8+ T cell-mediated immunity has remained poorly described in convalescent or vaccinated MM patients. Here, CD8A is linked to Miyoshi myopathy.